Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 524 clinical trials
featured
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects with Schizophrenia Treated Prospectively for 6-months with Abilify MyCite®

To compare inpatient psychiatric hospitalization rates (proportion of subjects with ≥ 1 inpatient psychiatric hospitalizations) between the retrospective period (Months 1 to 3) while subjects are on oral standard-of-care antipsychotic treatment and the prospective period (Months 1 to 3) after the subjects switch to Abilify MyCite®.  

  • 26 views
  • 23 Nov, 2020
  • 1 location
featured
  • 45 views
  • 23 Nov, 2020
  • 1 location
featured
A Study to Evaluate the Safety, Tolerability, and Effect of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult and Adolescent Patients with Schizophrenia

The primary objective of the study is to evaluate the long-term safety and tolerability of TV-46000 administered in adult and adolescent patients with schizophrenia.  

  • 19 views
  • 23 Nov, 2020
  • 1 location
featured
  • 51 views
  • 23 Nov, 2020
  • 1 location
featured
Schizophrenia with Changes in Thinking Skills

Local study doctors are conducting this clinical research study to learn more about an oral investigational drug that is taken with your current schizophrenia medication. They want to evaluate the safety and effectiveness of the investigational drug when it is taken once daily for 12 weeks.  All study-related visits, tests, …

  • 77 views
  • 23 Nov, 2020
  • 1 location
featured
Schizophrenia Relapse Prevention

This study tests whether the investigational drug prevents patients with schizophrenia from becoming worse.  This study looks at how well patients tolerate the investigational drug and how effective it is over 6 months.  All study-related visits and tests, as well as the study drug, will be provided at no cost.  …

  • 50 views
  • 23 Nov, 2020
  • 1 location
featured
Add-On Treatment for Schizophrenia Symptom Management

The primary objective of this study is to evaluate the effectiveness of NaBen® (sodium benzoate) (1000 mg/day) compared to Placebo (0 mg/day), in improving symptoms associated with schizophrenia in adults, when added to your current schizophrenia treatment.  

  • 42 views
  • 23 Nov, 2020
  • 1 location
featured
Treatment of Adolescents With Schizophrenia

This study is being conducted to determine the safety & efficacy of brexpiprazole monotherapy in the treatment of adolescents with schizophrenia.  

  • 36 views
  • 23 Nov, 2020
  • 1 location
featured
Study Seeking Patients with Schizophrenia

Study Seeking Patients with Schizophrenia

  • 0 views
  • 07 Nov, 2020
  • 6 locations
featured
Schizophrenia and Schizoaffective Disorders Study

Schizophrenia and Schizoaffective Disorders Study

  • 1456 views
  • 08 Nov, 2020
  • 1 location